Shrestha SB, Bhusal M, Jwarchan J, Gautam S, Shrestha PR. Efficacy and Safety of Intralesional Immunotherapy with Tuberculin Purified Protein Derivative among Cutaneous Wart Patients. J Nepal Health Res Counc [Internet]. 2023Jul.20 [cited 2025Oct.3];20(4):881-5. Available from: http://103.69.126.137/index.php/jnhrc/article/view/4233